Skip to main content

Table 3 Thyroid disease and diabetes mellitus screening measures among patients with and without celiac disease

From: Prevalence of markers of beta cell autoimmunity and thyroid disease in children with coeliac disease

 

Healthy controls (n = 200)

Mean of positive antibodies in healthy controls

Celiac disease (n = 95)

Mean of positive antibodies in patients with celiac disease

Relative between-group difference, % (95% CI)

Spearman’s rank correlation between t-Transglutaminase & antibodies

Thyroid disease, mean (SD)

      

TSH, mU/l

1.79 (1.66)

 

1.90 (1.92)

 

6.16 (-8.94 to 22.78)

0.085; p = 0.23

TRAb, U/l

1.83 (1.27)

3.6

2.00 (1.33)

5.6

9.50 (2.86 to 16.56)

0.255; p<0.001

Anti-Tg, U/l

10.02 (2.34)

621

8.99 (2.24)

174

-10.26 (-27.04 to 10.39)

-0.163; p = 0.01

Anti-TPO, U/l

2.17 (2.45)

185

2.32 (2.74)

-

6.69 (-15.29 to 34.39)

-0.036; p = 0.59

Diabetes mellitus, mean (SD)

      

Anti-GAD, U/ml

5.14 (1.25)

205.2

5.22 (1.43)

82.2

1.60 (-5.13 to 8.80)

0.026; p = 0.71

Anti-ZnT8, U/ml

10.55 (1.35)

52.5

10.97 (1.75)

343

4.04 (-5.95 to 15.08)

-0.023; p = 0.74

Anti-IA2, U/ml

15.29 (1.19)

62.4

15.56 (1.42)

432

1.76 (-4.34 to 8.24)

0.075; p = 0.276

Anti-insulin, U/ml

3.41 (1.32)

17.9

3.38 (1.41)

56

-0.75 (-7.92 to 6.98)

-0.020 ; p = 0.76

  1. TSH (thyroid stimulating hormone), TRAb (TSH receptor antibodies), anti-Tg (thyroglobulin antibodies), anti-TPO (thyroid peroxidase antibodies), anti-GAD (glutamic acid decarboxylase antibodies), ZnT8 (zinc transporter 8 antibodies), anti-IA2 (insulinoma antigen2 antibodies), CI (confidence interval)